Embozene Tandem Trademark Details
Word Mark | Embozene Tandem |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Celonova Biosciences, Inc. of Peachtree City, GA
View all trademarks for Celonova Biosciences, Inc.Serial Number | 85395551 |
---|---|
Status Date | Monday, April 6, 2015 |
Filing Date | Monday, April 6, 2015 |
Attorney | Scott D. Woldow |
Correspondent
Scott D. Woldow
SMITH, GAMBRELL & RUSSELL, LLP
Suite 400
1055 Thomas Jefferson St., NW
WASHINGTON DC 20007
SMITH, GAMBRELL & RUSSELL, LLP
Suite 400
1055 Thomas Jefferson St., NW
WASHINGTON DC 20007
Case File Statements
Goods & Services | Medical devices for embolization, namely, syringes and vials filled with embolic microspheres for embolization; Medical devices for embolization, namely, embolic microspheres for embolization in the form of particles; Medical devices for embolization, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical devices for embolization, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical devices for embolization, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical devices for embolization, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical microspheres for transarterial embolization of tumors, chemoembolization, transarterial chemoembolization, lesion devascularization, lobe devascularization, and proximal embolization; Medical microspheres for the treatment of hypervascular tumors and arteriovenous malformations; Medical microspheres for super selective, targeted chemoembolization of a hypervascular tissue or tumor; Drug delivery device, namely a drug delivery microsphere for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment; Drug delivery device, namely a drug delivery bead for carrying pharmaceuticals or drugs to a precise vasculature bed for localized treatment |
---|
Classifications
International Class Codes |
010
|
---|---|
U.S. Class Codes | 026, 039, 044 |
Status | 6 — Active |
Status Date | Tuesday, August 16, 2011 |
Primary Code | 010 |
Trademark Timeline
-
Aug 11 2011Trademark application filed with USPTO
-
Aug 15 2011New Application Entered In Tram
-
Aug 16 2011New Application Office Supplied Data Entered In Tram
-
Nov 23 2011Assigned To Examiner
-
Nov 25 2011Approved For Pub - Principal Register
-
Dec 14 2011Notification of Notice of Publication E-Mailed
-
Jan 03 2012Official Gazette Publication Confirmation E-Mailed
-
Jan 03 2012Published For Opposition
-
Feb 28 2012Noa E-Mailed - Sou Required From Applicant
-
Jul 10 2012Assigned To Examiner
-
Aug 28 2012Extension 1 Granted
-
Aug 28 2012Extension 1 Filed
-
Aug 28 2012Teas Extension Received
-
Aug 29 2012International filing request made
-
Aug 29 2012New Application For Ir Received
-
Aug 29 2012Automatically Certified
-
Aug 29 2012Ir Certified and Sent To Ib
-
Aug 30 2012Notice of Approval of Extension Request E-Mailed
-
Jan 11 2013Application For Ir Registered By Ib
-
Feb 28 2013Extension 2 Filed
-
Feb 28 2013Teas Extension Received
-
Mar 14 2013Extension 2 Granted
-
Mar 14 2013Case Assigned To Intent To Use Paralegal
-
Mar 15 2013Notice of Approval of Extension Request E-Mailed
-
Apr 26 2013Subsequent Designation Received
-
Apr 26 2013Subsequent Designation Sent To Ib
-
May 30 2013Teas Change of Correspondence Received
-
Jun 01 2013Subsequent Designation Processed By Ib
-
Aug 28 2013Extension 3 Filed
-
Aug 28 2013Teas Extension Received
-
Sep 06 2013Extension 3 Granted
-
Sep 07 2013Notice of Approval of Extension Request E-Mailed
-
Feb 28 2014Extension 4 Filed
-
Feb 28 2014Teas Extension Received
-
Mar 12 2014Extension 4 Granted
-
Mar 13 2014Notice of Approval of Extension Request E-Mailed
-
Apr 14 2014Subsequent Designation Received
-
Apr 14 2014Subsequent Designation Sent To Ib
-
May 22 2014Subsequent Designation Processed By Ib
-
Jun 04 2014Subsequent Designation Received
-
Jun 04 2014Subsequent Designation Sent To Ib
-
Jul 04 2014Subsequent Designation Processed By Ib
-
Aug 25 2014Extension 5 Filed
-
Aug 25 2014Teas Extension Received
-
Sep 02 2014Extension 5 Granted
-
Sep 03 2014Notice of Approval of Extension Request E-Mailed
-
Apr 06 2015Abandonment Notice Mailed - No Use Statement Filed
-
Apr 06 2015Abandonment - No Use Statement Filed
-
Oct 06 2015Total Ceasing of Effect To Be Processed
-
Oct 30 2015Ceasing of Effect Processed
-
Oct 30 2015Total Ceasing of Effect Notice Sent To Ib
-
Jan 30 2016Total Ceasing of Effect Processed By Ib
-
Jan 30 2016International Registration Cancelled By Ib